Sign Up to like & get
recommendations!
1
Published in 2019 at "Epidemiology"
DOI: 10.1158/1538-7445.am2019-3296
Abstract: Introduction: Improvements in blood-based biomarkers for distinguishing between indolent and aggressive prostate cancer are critical in enhancing the management of the disease. To address this, we have focused on the quantification of autoantibodies (AAbs) against…
read more here.
Keywords:
tumor antigens;
cancer;
prostate cancer;
sera ... See more keywords